Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
Łodyga M, Maciejewska K, Eder P, Waszak K, Stawczyk-Eder K, Michalak M, Dobrowolska A, Wiśniewska-Jarosińska M, Gąsiorowska A, Cicha M, Wierzba W, Rydzewska G.
Łodyga M, et al. Among authors: dobrowolska a.
Pol Arch Intern Med. 2021 Mar 30;131(3):226-232. doi: 10.20452/pamw.15796. Epub 2021 Feb 5.
Pol Arch Intern Med. 2021.
PMID: 33544564
Free article.